Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Enterococcus faecalis Infective Endocarditis
2013
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
The Tissue-Engineered Vascular Graft—Past, Present, and Future
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Early Results of Sarcomeric Gene Screening from the Egyptian National BA-HCM Program
2012
M-Mode and Two-Dimensional Echocardiography in Congenital Absence of the Pericardium
1982
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Mutations in β-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C 1 1Edited by J. Karn
1999
Excess mortality and morbidity in patients surviving infective endocarditis
2012
American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease
2013 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Management of infective endocarditis: challenges and perspectives
2012
Infective endocarditis
2015
Clinical and genetic issues in familial dilated cardiomyopathy
2005
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
2015 Standout
A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.
1998
Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy
2008
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations
2011
Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia
2010
Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy
2004
Sudden cardiac death in familial hypertrophic cardiomyopathy: are “benign” mutations really benign?
1997
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
2007 Standout
Hypertrophic Cardiomyopathy
2002 Standout
Infective Endocarditis Epidemiology Over Five Decades: A Systematic Review
2013
Early changes of right heart geometry after pulmonary thromboendartcrectomy
1988
Heart disease and other causes of sudden death in young athletes
1998
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
1998 Standout
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Progress With Genetic Cardiomyopathies
2009
Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic Cardiomyopathy
2012
Verapamil
1978
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
2000 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits
2004 Standout
An echocardiographic index for separation of right ventricular volume and pressure overload
1985
Effects of verapamil on myocardial performance in coronary disease.
1979
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony.
1989 Standout
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Preservation of high-energy phosphates by verapamil in reperfused myocardium.
1984
Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy
2008
Quantitative Assessment of Coronary Vasoreactivity in Humans In Vivo
1995
Familial Hypertrophic Cardiomyopathy
1998
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Clinical Characterization of Left Ventricular Noncompaction in Children
2003
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Right ventricular function in adult cardiovascular disease
1982
Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study.
1983
Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel".
1979
Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem
1980 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Mitochondrial pathology in cardiac failure
2001
Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management
2001
Creatine and Creatinine Metabolism
2000 Standout
Works of D. Richmond being referenced
The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy
1997
Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease
2005
Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis
2009
DNA testing in familial hypertrophic cardiomyopathy: clinical and laboratory implications
1996
Isolated Noncompaction of the Myocardium
2002
The mechanism of abnormal septal motion in atrial septal defect: pre- and postoperative study by radionuclide ventriculography in adults.
1981
Pathophysiology of coronary artery spasm.
1982
Counselling issues in familial hypertrophic cardiomyopathy.
1998
Cardiovascular action of verapamil in the dog with particular reference to myocardial contractility and atrioventricular conduction
1976
Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene.
1998